1,269 research outputs found

    Mary Ann Weston Maughan, Midwife record, 1853-1892

    No full text
    Mary Ann Weston Maughan, Midwife record, 1853-1892; Council of Health; Tooele and Cache Counties. The diary includes Mary Ann Weston Maughan's midwife records for 1853-1892. Each entry includes the child's name, parents' names, and date of birth. Some entries also include a death date for the child. Maughan included entries for the births of her children with husband Peter. Also includes birth record of George T Benson, father of LDS prophet Ezra Taft Benson. The record includes births in both Tooele and Cache Counties, Utah

    David Maughan

    No full text
    David Maughan was born on 5 February 1873 at Paddington, Sydney, the son of John Maughan and his wife Bertha Windeyer nee Thompson. He was educated at the King's School, Parramatta, where he won the Broughton and Forrest Exhibition, a scholarship given to ex-students of King's School who qualify to attend Oxford or Cambridge University. He attended Balliol College, University of Oxford, from 1891 to 1895, graduating with a BA 1895 and Bachelor of Civil Law (BCL) First class in 1896. He tutored in law at Balliol in 1896. In 1906 his BA was recognised 'ad eundem gradua' by the University of Sydney. In 1912 he graduated from Oxford University with an MA and BCL. This was recognised by the University of Sydney as an MA and LLB in 1914.(1)<br /><br />Maughan was called to the Bar of Lincoln's Inn on 17 June 1896. After returning to Sydney, he was called to the Bar of New South Wales on 16 November 1896. At first he specialised in equity cases, but he became expert in constitutional law. His appointment as a King's Counsel was recommended by the Executive Council on 29 October 1919. (2)<br /><br />Maughan was active in legal professional organisations. He was a member of the Council of the Bar of New South Wales from 1913/14 to 1918/19 and in 1935/36. He was a member of the NSW Bar Association from its incorporation in 1936 until 1942/43. He was Vice-president from 1940/41 to 1942/43. Maughan was a member of the NSW Barristers Admission Board from 1939 to 1941. He was President of the Law Council of Australia from 1941 to 1945. (3)<br /><br />Maughan acted as a Supreme Court Judge on a number of occasions. In 1924 he acted in all jurisdictions of the Court for six months, beginning on 28 July. In 1936 he acted in the Equitable jurisdiction from 6 May 1936 to 1 August 1936 inclusive; and in all jurisdictions from 2 August to 31 March 1937. (4)<br /><br />Maughan took an active role in constitutional matters. He opposed moves in 1930 by the Premier of New South Wales, J T Lang, to abolish the Legislative Council. When the Council passed Lang's bills to abolish itself, Maughan obtained a Supreme Court decision that the bills needed approval from a referendum of the people. He was a counsel in appeals to the High Court of Australia and Privy Council in 1932 over the Legislative Council and to the Privy Council in 1934 over a mechanism to settle deadlocks between the houses of Parliament. Maughan publically opposed the Administration of Justice Bill in 1931 which would have amalgamated the two branches of the legal profession. He also opposed Australia's adoption of the Statute of Westminster, 1931. This Act, passed by the Parliament of the United Kingdom, gave legislative independence from the United Kingdom to the self-governing dominions of the British Empire, but only if they adopted the Act. Australia did not adopt it until 1942 and then only to clarify government war powers. Maughan was a strong supporter of civil and State's rights and during World War II opposed increasing governmental controls such as the National Security Act. He appeared before the High Court in important Constitutional cases such as the uniform tax case in 1942 and airlines case in 1945. (5)<br /><br />Maughan's publications included 'Constitutional Revision in Australia' (1944), a publication of four lectures given at the Winter Forum Series of the Australian Institute of Political Science held in Sydney 5 to 26 July 1944, 'The Statute of Westminster' (1932) and 'The Statute of Westminster' (1939), the latter was a reprint of a paper read at the fourth convention of the Law Council of Australia, July 1939. <br /><br />Maughan was active both in sport and in the community. He was a mountaineer, walker and surfer. From the 1920s to the 1950s, he was president of the Athletic Association of the Great Public Schools of New South Wales, vice-president of the New South Wales Rowing Association, and vice-president of the New South Wales Rugby Union. In the 1920s and 1930s he was vice-president of the King's School Old Boys Union and chairman of Directors of the University Club, Sydney. In the 1930s he was a member of the Council of King's School, chairman of the Oxford Society (NSW Branch), chairman of the Free Library Movement, a Councillor of the Big Brother Movement and a Director of Royal Prince Alfred Hospital, and from 1933 to 1941 president of the Australian Institute of International Affairs (New South Wales Branch). He was knighted in 1951 for his public service. (6)<br /><br />Maughan married Jean Alice Barton on 30 March 1909 at Darling Point. Jean was the daughter of Sir Edmund Barton. Maughan died on 3 November 1955 at Royal Prince Alfred Hospital, survived by his wife, son and daughter. (7)<br /><br />Endnotes<br />1. Anthony Fisher, 'Maughan, Sir David (1873-1955), Australian Dictionary of Biography, Online Edition, <a href="http://www.adb.online.edu.au/biogs/A100443b.htm">http://www.adb.online.edu.au/biogs/A100443b.htm</a> (cited 11 January 2008); Fred Johns, Who's Who in Commonwealth of Australia, Sydney, Angus and Robertson, 1922, pp.188-89; 1927-8, p.178; 1933, p.223; 1935, p.329; 1938, p.354; 1941, p.473; 1944, p.582; 1947, p.588; 1950, pp.491-92; 1955, p.532; The Balliol College Register, published 1934, Google Book Search, <a href="http://books.google.com.au/books?id=yG1JAAAAMAAJ&q=maughan+david+oxford&dq=maughan+david+oxford&1r=&pgis=1">http://books.google.com.au/books?id=yG1JAAAAMAAJ&q=maughan+david+oxford&dq=maughan+david+oxford&1r=&pgis=1</a> (cited 21 April 2008); University of Sydney Calendar, 1906, p.338; 1915, p.567 <a href="http://calendararchive.usyd.edu.au/index.php">http://calendararchive.usyd.edu.au/index.php</a> (cited 21 April 2008).<br />2. Barristers Admission Board; NRS 13665, Roll of Barristers, 1876-1926; Reel 2147, p.10; New South Wales Government Gazette, No.253, 7 November 1919, p.6096; Attorney General's Department [III]; NRS 333, Letters received - Special Bundles, 1874-1984; [10/42918] Correspondence re appointment of King's Counsels, 1898-1941.<br />3. 'Bar Councillors 1902-2006', New South Wales Bar Association, <a href="http://www.nsw.bar.asn.au/docs/about/history/bclist1910_1920.php ">http://www.nsw.bar.asn.au/docs/about/history/bclist1910_1920.php</a> (cited 22 January 2008); New South Wales Law Almanac, Sydney, NSW Government Printer, various, 1936, p.58; 1937, p.59; 1938, pp.58-9; 1939, pp.58-9; 1940, pp.60-61; 1941, p.60-61; 1942, pp.60-61, 1943, p.60; 'Law Council of Australia - Law Council Past Presidents', <a href="http://www.lawcouncil.asn.au/pastpres.html">http://www.lawcouncil.asn.au/pastpres.html</a> (cited 21 April 2008).<br />4. State Reports New South Wales, Sydney, Law Book Company of Australasia Pty Ltd, Vol.24 (1924), Vol.36 (1936), Vol.37 (1937); NSW Government Gazette, No.96, 25 July, 1924, p.3696; No.79, 8 May 1936, p.1862; No.114, 17 July 1936, p.2972; No.193, 27 November 1936, p.4877; No.9, 22 January 1937, p.290.<br />5. ADB, op.cit.; 'Statute of Westminster 1931', Wikipedia, <a href="http://en.wikipedia.org/wiki/Statute_of_Westminster_1931">http://en.wikipedia.org/wiki/Statute_of_Westminster_1931</a> (cited 21 April 2008).<br />6. Fred Johns, Who's Who in the Commonwealth of Australia, op.cit; ADB, op.cit.<br />7. ADB, ibid.PER-116Acting Judge, Supreme Court of NSW, 28/07/1924 - 27/01/1925<br/>Acting Judge, Supreme Court of NSW, Equity Jurisdiction, 06/05/1936 - 01/08/1936<br/>Acting Judge, Supreme Court of NSW, 02/08/1936 - 31/03/1937<br/>Member, New South Wales Barristers Admission Board, 1939 - 1941<br/>President, Law Council of Australia, 1941 - 1945<br/&gt

    B-2085a: J. Charles and Wynona Maughan residence. NW 1/4 Sec 7 T 12 N R 1 E. Built 1954

    No full text
    B-2085a: J. Charles and Wynona Maughan residence. NW 1/4 Sec 7 T 12 N R 1 E. Built 195

    Motivations for Food Consumption during Specific Eating Occasions in Turkey

    No full text
    Citation: Chambers, D., Phan, U. T. X., Chanadang, S., Maughan, C., Sanchez, K., Di Donfrancesco, B., . . . Esen, E. (2016). Motivations for Food Consumption during Specific Eating Occasions in Turkey. Foods, 5(2), 14. doi:10.3390/foods5020039Several studies in different countries have been conducted to investigate factors affecting food choices. The objective of this study was to understand the motivations of specific food and beverage choices for different eating occasions in a typical diet of the Turkish people. A convenience sample of 141 respondents from seven different geographical regions in Turkey completed an online survey questionnaire that included questions about demographic information and details about their latest eating occasion. Respondents reported all of their motivations for choosing each food/beverage item reported for that specific eating occasion. Results indicated that different motivations played different roles in food choices of people in Turkey. Liking was a key characteristic for all eating occasions, but key natural concerns were even more important at breakfast, and need and hunger were more important for a mid-afternoon snack. Lunch involved additional motivations such as Sociability, Variety Seeking, and Social Norms. In addition to Liking, choices of different food groups were also driven by other motivations such as Habits, Convenience, Need and Hunger, Natural Concerns, and Health. This study helped better understand the current dietary patterns of Turkish people as well as the motives underlying their choices of foods and beverages for different meals and snacks. These findings could be useful for dietary campaigns that aim to improve eating behaviors in Turkey

    Threats and offers in community mental health care

    No full text
    Making threats and offers to patients is a strategy used in community mental healthcare to increase treatment adherence. In this paper, an ethical analysis of these types of proposal is presented. It is argued (1) that the primary ethical consideration is to identify the professional duties of care held by those working in community mental health because the nature of these duties will enable a threat to be differentiated from an offer, (2) that threatening to act in a way that would equate with a failure to uphold the requirements of these duties is wrong, irrespective of the benefit accrued through treatment adherence and (3) that making offers to patients raises a number of secondary ethical considerations that need to be judged on their own merit in the context of individual patient care. The paper concludes by considering the implications of these arguments, setting out a pathway designed to assist community mental healthcare practitioners to determine whether making a specific proposal to a patient is right or wrong

    Cetuximab therapy in first-line metastatic colorectal cancer and intermittent palliative chemotherapy: review of the COIN trial.

    No full text
    The aim of palliative chemotherapy is to increase survival whilst maintaining maximum quality of life for the individual concerned. It is evident that the survival advantage offered by palliative chemotherapy for metastatic colorectal cancer has increased incrementally with the addition of each newly licensed therapeutic agent. More recently, advances in the field have led to the introduction of targeted monoclonal antibodies, whose benefits are documented in clinical trials and are acknowledged in their approval and licensing. Whilst we are continuing to explore the optimum use of the more traditional chemotherapy agents, with respect to both quantity and quality of life, these novel agents are battling to find their optimum place in the armamentarium. It is evident that a continuing add-one-in policy is likely to be detrimental to both patient and budget. Defining the positioning and duration of these combination therapies has become the subject of much debate and numerous current clinical trials. The Medical Research Council COIN trial is one of these trials, with a remit to explore further the optimum use of both standard agents and novel agents in the first-line setting for metastatic colorectal cancer

    Chandra x-ray analysis of the massive high-redshift galaxy clusters C1J1113.1-2615

    No full text
    We present an analysis of Chandra observations of two high-redshift clusters of galaxies, Cl J1113.1-2615 at z = 0.725 and Cl J0152.7-1357 at z = 0.833. We find Cl J1113.1-2615 to be morphologically relaxed with a temperature of kT = 4.3(-0.4)(+0.5) keV and a mass (within the virial radius) of 4.3(-0.7)(+0.8) x 10(14) M-circle dot. Cl J0152.7-1357, by contrast, is resolved into a northern and southern subcluster, each massive and X-ray luminous, in the process of merging. The temperatures of the subclusters are found to be 5.5(-0.8)(+0.9) and 5.2(-0.9)(+1.1) keV, respectively, and we estimate their respective masses to be 6.1(-1.5)(+1.7) x 10(14) and 5.2(-1.4)(+1.8) x 10(14) M-circle dot within the virial radii. A dynamical analysis of the system shows that the subclusters are likely to be gravitationally bound. If the subclusters merge, they will form a system with a mass similar to that of the Coma Cluster. Two-dimensional modeling of the X-ray surface brightness reveals excess emission between the subclusters, suggestive, but not conclusive, evidence of a shock front. We make a first attempt at measuring the cluster M-T relation at z approximate to 0.8 and find no evolution in its normalization, supporting the previous assumption of an unevolving M-T relation when constraining cosmological parameters from cluster evolution studies. A comparison of the cluster properties with those of nearby systems also finds little or no evolution in the L-T relation, the gas fraction-T relation, the beta-T relation, or the metallicity. These results suggest that, in at least some massive clusters, the hot gas was in place, and containing its metals, at z approximate to 0.8 and thus that the clusters were assembled at redshifts significantly higher than z = 0.8, as predicted in low-Omega(M) models. We also highlight the need to correct for the degradation of the Chandra ACIS low-energy quantum efficiency in high-redshift cluster studies when the low-energy absorption is often assumed to be the Galactic value, rather than measured

    Colorectal cancer in the adjuvant setting: perspectives on treatment and the role of prognostic factors

    No full text
    In patients with stage III colorectal cancer (CRC) who have undergone potentially curative resection, adjuvant treatment with 6 months' of 5-fluorouracil (5-FU) plus folinic acid (FA) is generally accepted as standard treatment and leads to a 5\% to 10\% improvement in absolute survival when compared with a no-chemotherapy control. In stage II CRC, the benefit of adjuvant chemotherapy has yet to be established. In metastatic CRC, randomized trials of irinotecan have consistently demonstrated that use of the drug, either alone or in combination with 5-FU/FA, prolongs survival. To investigate whether this benefit can be extended to patients with earlier disease, a series of multicenter trials are randomizing stage III colon cancer patients to adjuvant 5-FU/FA regimens with or without the addition of irinotecan. The role of adjuvant irinotecan is also being assessed in stage II colon cancer and in patients with rectal tumors. The risk/benefit ratio of adjuvant therapy in both stage III and stage II disease would be decreased if patients at the highest risk of relapse could be identified. Data from retrospective analyses suggest that DNA indexes, angiogenesis and some genetic/biological markers (loss of heterozygosity at chromosome 18 and the presence of microsatellite instability) identify prognostic differences in colon cancer patients. Their value as a guide to the intensity of adjuvant therapy required should be tested by randomized trial, as should the use of markers such as thymidilate synthase overexpression as a means of tailoring drug choice to tumor characteristics

    FRAGMATIC: A randomised phase III clinical trial investigating the effect of <b>fragm</b>in<sup>® </sup><b>a</b>dded to standard <b>t</b>herapy <b>i</b>n patients with lung <b>c</b>ancer

    No full text
    Abstract Background Venous thromboembolism (VTE) occurs when blood clots in the leg, pelvic or other deep vein (deep vein thrombosis) with or without transport of the thrombus into the pulmonary arterial circulation (pulmonary embolus). VTE is common in patients with cancer and is increased by surgery, chemotherapy, radiotherapy and disease progression. Low molecular weight heparin (LMWH) is routinely used to treat VTE and some evidence suggests that LMWH may also have an anticancer effect, by reduction in the incidence of metastases. The FRAGMATIC trial will assess the effect of adding dalteparin (FRAGMIN), a type of LMWH, to standard treatment for patients with lung cancer. Methods/Design The study design is a randomised multicentre phase III trial comparing standard treatment and standard treatment plus daily LMWH for 24 weeks in patients with lung cancer. Patients eligible for this study must have histopathological or cytological diagnosis of primary bronchial carcinoma (small cell or non-small cell) within 6 weeks of randomisation, be 18 or older, and must be willing and able to self-administer 5000 IU dalteparin by daily subcutaneous injection or have it administered to themselves or by a carer for 24 weeks. A total of 2200 patients will be recruited from all over the UK over a 3 year period and followed up for a minimum of 1 year after randomisation. Patients will be randomised to one of the two treatment groups in a 1:1 ratio, standard treatment or standard treatment plus dalteparin. The primary outcome measure of the trial is overall survival. The secondary outcome measures include venous thrombotic event (VTE) free survival, serious adverse events (SAEs), metastasis-free survival, toxicity, quality of life (QoL), levels of breathlessness, anxiety and depression, cost effectiveness and cost utility. Trial registration Current Controlled Trials ISRCTN80812769</p

    Domestic and foreign corporation study, state salary comparisons and life insurance survey.

    No full text
    George M. Miller, chairman."Tables 11" and Errata" (1 leaf, mimeographed) mounted on 2nd preliminary leaf.On cover: ... Report of Sub-committee on Corporation Activities to the Governor and State Legislature.At head of title: State of Utah. Investigating Committee of Utah Governmental Units.Foreign and domestic corporations, by Theodore Maughan and Robert Funk.--An Analysis of the salary practices of the State of Utah, by Elmer Young.--The quest of security in Utah through life insurance, by T. W. Peterson.Mode of access: Internet
    corecore